ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 21.7% | 19.1% | 10.7% | 98.9% | 99.3% | 97.9% | 97.8% | 96.3% | 95.3% | 90.4% | 100.0% | 100.0% | |
| 18.3% | 17.1% | 8.8% | 97.4% | 95.9% | 38.2% | 93.4% | 94.3% | 92.2% | 66.2% | 3.7% | 90.9% | |
| 18.3% | 17.1% | 8.8% | 97.4% | 95.9% | 95.5% | 93.4% | 94.3% | 92.2% | 66.2% | 3.7% | 90.9% | |
| 0.1% | – | – | – | – | 0.0% | – | – | – | 0.0% | 91.3% | 0.0% | |
| 41.7% | 29.6% | – | – | – | – | – | – | – | – | – | – | |
| 35.9% | 50.1% | 87.8% | – | – | – | – | – | – | – | – | – | |
| 17.5% | 37.5% | 50.6% | 13.8% | 15.4% | 38.6% | 61.4% | 50.4% | 150.5% | 1,420.0% | 917.7% | 325.9% | |
| 5.5% | 4.0% | 4.0% | 13.8% | 15.4% | 20.0% | 37.2% | 22.1% | 109.3% | 1,325.8% | 917.7% | 325.9% | |
| – | – | – | – | – | 8.2% | 21.3% | 1.5% | 22.2% | 137.4% | 219.1% | 19.0% | |
| – | 1.2% | – | 6.2% | 1.5% | 3.2% | 1.8% | 3.1% | 14.3% | 332.9% | 179.6% | 51.5% | |
| – | – | – | – | – | – | – | – | 40.5% | 94.2% | – | – | |
| 82.5% | 62.5% | 49.4% | 86.2% | 84.6% | 61.4% | 38.6% | 49.6% | -50.5% | -1,320.0% | -817.7% | -225.9% | |
| -264.8% | -548.3% | -1,253.3% | -157.2% | -169.9% | -232.4% | -648.1% | -528.0% | -1,299.0% | -17,023.5% | -9,898.7% | -5,703.6% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.3% | 0.4% | 0.9% | 13.7% | 11.5% | 21.3% |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.